These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3127197)

  • 1. Safety of valproate in porphyria cutanea tarda.
    D'Alessandro R; Rocchi E; Cristina E; Cassanelli M; Benassi G; Pizzino D; Baldrati A; Baruzzi A
    Epilepsia; 1988; 29(2):159-62. PubMed ID: 3127197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodular focal fatty infiltration of the liver in acquired porphyria cutanea tarda.
    Flueckiger F; Steiner H; Leitinger G; Hoedl S; Deu E
    Gastrointest Radiol; 1991; 16(3):237-9. PubMed ID: 1879640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute intermittent porphyria and epilepsy: safety of clonazepam.
    Suzuki A; Aso K; Ariyoshi C; Ishimaru M
    Epilepsia; 1992; 33(1):108-11. PubMed ID: 1733741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate monotherapy in 30 patients with partial seizures.
    Dean JC; Penry JK
    Epilepsia; 1988; 29(2):140-4. PubMed ID: 3127196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1988; 29(6):794-804. PubMed ID: 3142761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report.
    Gaida-Hommernick B; Rieck K; Runge U
    Epilepsia; 2001 Jun; 42(6):793-5. PubMed ID: 11422339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyria cutanea tarda in association with the human immunodeficiency virus infection.
    Ong EL; Ellis ME; McDowell D; Gebril M; Weinkove C; Ead R
    Postgrad Med J; 1988 Dec; 64(758):956-7. PubMed ID: 3256816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of primary liver cancer and its relation to porphyria cutanea tarda and porphyria acuta intermittens.
    Hardell L
    IARC Sci Publ; 1986; (77):591-2. PubMed ID: 3596757
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus infection and porphyria cutanea tarda.
    Hogan D; Card RT; Ghadially R; McSheffrey JB; Lane P
    J Am Acad Dermatol; 1989 Jan; 20(1):17-20. PubMed ID: 2913079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Report of a case.
    Callen JP; Ross L
    J Am Acad Dermatol; 1981 Sep; 5(3):269-73. PubMed ID: 7263973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard approach to antiepileptic drug treatment in the United States.
    Pellock JM
    Epilepsia; 1994; 35 Suppl 4():S11-8. PubMed ID: 8174515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda and scleroderma--chance association or related disease: a case report.
    Sigal M; Nahum HD; Crickx B; Bilet S; Mourier-Massicot C; Belaich S
    Clin Exp Dermatol; 1990 Jul; 15(4):285-8. PubMed ID: 2208778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is porphyria cutanea tarda a risk factor in the development of hepatocellular carcinoma? A case report and review of the literature.
    Packe GE; Clarke CW
    Oncology; 1985; 42(1):44-7. PubMed ID: 2982117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of valproate in porphyria.
    Garcia-Merino JA; Lopez-Lozano JJ
    Lancet; 1980 Oct; 2(8199):856. PubMed ID: 6107519
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication.
    Duncan JS; Patsalos PN; Shorvon SD
    Epilepsia; 1991; 32(1):101-15. PubMed ID: 1985818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function with antiepileptic drugs.
    Isojärvi JI; Pakarinen AJ; Myllylä VV
    Epilepsia; 1992; 33(1):142-8. PubMed ID: 1733749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.